HLA–DRB1*01 and macrophagic myofasciitis
Sandrine Guis MD
Hôpital de la Conception
Drs. Guis and Pellissier contributed equally to this work.
Search for more papers by this authorJean-François Pellissier MD
Hôpital la Timone
Drs. Guis and Pellissier contributed equally to this work.
Search for more papers by this authorDenis Reviron MD, PhD
Etablissement Français de Sang–Alpes-Méditerranée
Search for more papers by this authorJean-Pierre Mattei MD
Hôpital de la Conception, Marseille, France
Search for more papers by this authorRomain K. Gherardi MD, PhD
Hôpital Henri Mondor, Créteil, France
Search for more papers by this authorJean Roudier MD, PhD
Hôpital de la Conception and INSERM EMI9940, Marseille, France
Search for more papers by this authorSandrine Guis MD
Hôpital de la Conception
Drs. Guis and Pellissier contributed equally to this work.
Search for more papers by this authorJean-François Pellissier MD
Hôpital la Timone
Drs. Guis and Pellissier contributed equally to this work.
Search for more papers by this authorDenis Reviron MD, PhD
Etablissement Français de Sang–Alpes-Méditerranée
Search for more papers by this authorJean-Pierre Mattei MD
Hôpital de la Conception, Marseille, France
Search for more papers by this authorRomain K. Gherardi MD, PhD
Hôpital Henri Mondor, Créteil, France
Search for more papers by this authorJean Roudier MD, PhD
Hôpital de la Conception and INSERM EMI9940, Marseille, France
Search for more papers by this author
REFERENCES
- 1 Gherardi RK, Coquet M, Chérin P, Authier FJ, Laforêt P, Bélec L, et al. Macrophagic myofasciitis: an emerging entity. Lancet 1998; 352: 347–52.
- 2 Authier FJ, Cherin P, Creange A, Bonnotte B, Ferrer X, Abdelmoumni A, et al. Central nervous system disease in patients with macrophagic myofasciitis. Brain 2001; 124: 974–83.
- 3 Gherardi RK, Coquet M, Chérin P, Bélec L, Moretto P, Dreyfus PA, et al. Macrophagic myofasciitis lesions assess long-term persistence of vaccine-derived aluminium hydroxide in muscle. Brain 2001; 124: 1821–31.
- 4 Guis S, Mattei JP, Nicoli F, Pellissier JF, Kaplanski G, Figarella-Branger D, et al. Identical twins with macrophagic myofasciitis: genetic susceptibility and triggering by aluminic vaccine adjuvants? Arthritis Rheum. In press.
- 5 Miller SA, Dykes DD, Polesky HF. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res 1988; 16: 1215.
- 6 Bignon JD, Fernandez-Vin̆a MA. PCR-SSO protocol for the HLA-DNA typing technique. In: D Charron, R Fauchet, editors. 12th International Histocompatibility Workshop reference protocol addendum technical handbook. Paris: HLA et medicine; 1996. p. 4.
- 7 Olerup O, Zetterquist H. HLA-DR typing by PCR amplification with sequence-specific primers (PCR-SSP) in two hours: an alternative to serological DR typing in clinical practice including donor-recipient matching in cadaveric transplantation. Tissue Antigens 1992; 39: 225–35.
- 8
Haldane J.
The estimation and significance of the logarithm of a ratio of frequencies.
Ann Hum Genet
1996;
20:
309.
10.1111/j.1469-1809.1955.tb01285.x Google Scholar
- 9 Benazet JF, Reviron D, Mercier P, Roux H, Roudier J. HLA-DRB1 alleles associated with rheumatoid arthritis in Southern France: absence of extraarticular disease despite expression of the shared epitope. J Rheumatol 1995; 22: 607–10.
- 10 Reviron D, Foutrier C, Guis S, Mercier P, Roudier J. DRB1 alleles in polymyalgia rheumatica and rheumatoid arthritis in southern France. Eur J Immunogenet 2001; 28: 83–7.
- 11 Haworth S, Ridgeway J, Stewart I, Dyer P, Pepper L, Ollier W. Polymyalgia rheumatica is associated with both HLA-DRB1*0401 and DRB1*0404. Br J Rheumatol 1996; 35: 632–5.
- 12 Gough A, Faint J, Salmon M, Hassell A, Wordsworth P, Pilling D, et al. Genetic typing of patients with inflammatory arthritis at presentation can be used to predict outcome. Arthritis Rheum 1994; 37: 1166–70.
